Howard L. Kaufman

机构：Massachusetts Eye and Ear Infirmary, Harvard University, Massachusetts General Hospital, Q Therapeutics (United States), Global Cancer Institute · ORCID：0000-0003-1131-004X

发表论文 549 篇 · 总被引 27205 次 · h-index 77

代表论文

• Promoting the therapeutic potential of interleukin-7 (IL-7) by expression in viral vectors (2025 · Cancer Gene Therapy · 被引 8)
• Immune Checkpoint Inhibitors for Advanced Periocular/Orbital Squamous Cell Carcinoma of Cutaneous Origin: Durable Responses in a Retrospective Cohort (2026 · Ophthalmic Plastic and Reconstructive Surgery)
• Frontline immunotherapy with response-guided subsequent treatment (FIRST) in cutaneous squamous cell carcinoma: a Bayesian causal analysis of dose intensity, early benefit, and treatment de-escalation (2026 · Journal for ImmunoTherapy of Cancer)
• Supplementary Table S4 from Preclinical Evaluation of an Anchored Immunotherapy Strategy with Aluminum Hydroxide–Tethered IL-12 in Dogs with Advanced Malignant Melanoma (2026)
• Supplementary Figure S6 from Preclinical Evaluation of an Anchored Immunotherapy Strategy with Aluminum Hydroxide–Tethered IL-12 in Dogs with Advanced Malignant Melanoma (2026)
• Supplementary Figure S8 from Preclinical Evaluation of an Anchored Immunotherapy Strategy with Aluminum Hydroxide–Tethered IL-12 in Dogs with Advanced Malignant Melanoma (2026)